Journal of Antimicrobial Chemotherapy, Vol 41, 25-41, Copyright © 1998 by The British Society for Antimicrobial Chemotherapy
DM Livermore
Clinical use of beta-lactams has selected for beta-lactamase-producing
organisms. Numerous beta-lactamases are known, and sequencing allows them
to be divided into four Classes, A to D, with Classes A and C being the
most important. Pharmaceutical chemists have responded to the spread of
beta-lactamase-producing organisms by developing stable agents and
inhibitors. Stability in penicillins and cephalosporins is achieved by
attaching a bulky substituent to the amino group of 6- aminopenicillanic
acid or 7-aminocephalosporanic acid, or by replacing the hydrogen on carbon
6 (penicillins) or 7 (cephalosporins) with an alpha-methoxy group. In
carbapenems, stability is achieved by incorporation of a simple
trans-6-hydroxyethyl group. Beta-lactamase- inhibitory activity occurs in
many beta-lactam classes but only clavams and penicillanic acid sulphones
have been developed specifically as beta-lactamase inhibitors. These
inhibit most Class A and some Class D enzymes but act poorly against Class
B and C enzymes. Their success is affected by the amount of enzyme, the
permeability of the bacterial cell wall, the partner beta-lactam and the
pH. Piperacillin/tazobactam, which combines a good inhibitor of Class A
enzymes with a broad- spectrum, easily-protected penicillin, has wide
activity against common pathogens, the major exceptions being strains of
Enterobacter, Serratia and Citrobacter freundii that produce large amounts
of Class C enzymes, and Gram-positive cocci with modified
penicillin-binding proteins. Beta- lactamase-stable beta-lactams and
inhibitor combinations overcome many existing resistance mechanisms but are
themselves selecting new resistances. Few new beta-lactams able to overcome
these resistances are advanced in development and consequently the
opportunities for control lie mostly in the more prudent use of compounds
already available.
ORIGINAL ARTICLES
Beta-lactamase-mediated resistance and opportunities for its control
Central Public Health Laboratory, London, UK. d.m.livermore@mds.amw.ac.uk
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  S. See, E. K Scott, and M. W Levin Penicillin-Induced Jarisch-Herxheimer Reaction Ann. Pharmacother., December 1, 2005; 39(12): 2128 - 2130. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. G. Winstanley, H. K. Parsons, M. A. Horstkotte, I. Sobottka, and E. Sturenburg Phenotypic detection of {beta}-lactamase-mediated resistance to oxyimino-cephalosporins in Enterobacteriaceae: evaluation of the Mastascan Elite Expert System J. Antimicrob. Chemother., August 1, 2005; 56(2): 292 - 296. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.-I. Kang, H. Pai, S.-H. Kim, H.-B. Kim, E.-C. Kim, M.-d. Oh, and K.-W. Choe Cefepime and the inoculum effect in tests with Klebsiella pneumoniae producing plasmid-mediated AmpC-type {beta}-lactamase J. Antimicrob. Chemother., December 1, 2004; 54(6): 1130 - 1133. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. W. Stone, Q. Zhang, R. Castillo, V. R. Doppalapudi, A. R. Bueno, J. Y. Lee, Q. Li, M. Sergeeva, G. Khambatta, and N. H. Georgopapadakou Mechanism of Action of NB2001 and NB2030, Novel Antibacterial Agents Activated by {beta}-Lactamases Antimicrob. Agents Chemother., February 1, 2004; 48(2): 477 - 483. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Sanguinetti, B. Posteraro, T. Spanu, D. Ciccaglione, L. Romano, B. Fiori, G. Nicoletti, S. Zanetti, and G. Fadda Characterization of Clinical Isolates of Enterobacteriaceae from Italy by the BD Phoenix Extended-Spectrum {beta}-Lactamase Detection Method J. Clin. Microbiol., April 1, 2003; 41(4): 1463 - 1468. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. H. Toney, G. G. Hammond, P. M. D. Fitzgerald, N. Sharma, J. M. Balkovec, G. P. Rouen, S. H. Olson, M. L. Hammond, M. L. Greenlee, and Y.-D. Gao Succinic Acids as Potent Inhibitors of Plasmid-borne IMP-1 Metallo-beta -lactamase J. Biol. Chem., August 17, 2001; 276(34): 31913 - 31918. [Abstract] [Full Text] [PDF]
|
|